-
A-1210477
- names:
A-1210477
- CAS号:
1668553-26-1
MDL Number: - MF(分子式): C46H55N7O7S MW(分子量): 850.04
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM001612-10mg | 10mg | 98.89% | ¥ 2295.00 | ¥ 2295.00 | 2-3天 | ¥ 0.00 | ||
| YZM001612-5mg | 5mg | 98.89% | ¥ 1300.00 | ¥ 1300.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 1668553-26-1 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C46H55N7O7S |
| 分子量 Molecular Weight | 850.04 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度10 mg/mL(11.76 mM;Need ultrasonic)H2O< 0.1 mg/mL(insoluble) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
A-1210477(CAS:1668553-26-1)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | A-1210477 是一种有效的,选择性的MCL-1抑制剂,Ki值为 0.45 nM |
| Introduction | A210477 is a potent and selective inhibitor of MCLwith aKiof 0.45 nM. |
| Application1 | |
| Application2 | |
| Application3 |
A-1210477 是一种有效的,选择性的MCL-1抑制剂,Ki值为 0.45 nM。A-1210477 is a potent and selective inhibitor ofMCL-1with aKiof 0.45 nM.
【1】.Leverson JD, et al. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax). Cell Death Dis. 2015 Jan 15;6:e1590.
【2】.Milani M, et al. DRP-1 is required for BH3 mimetic-mediated mitochondrial fragmentation and apoptosis. Cell Death Dis. 2017 Jan 12;8(1):e2552
【3】.Kawakami H, et al. Mutant BRAF Upregulates MCL-1 to Confer Apoptosis Resistance that Is Reversed by MCL-1 Antagonism and Cobimetinib in Colorectal Cancer. Mol Cancer Ther. 2016 Dec;15(12):3015-3027
【4】.Phillips DC, et al. Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199). Blood Cancer J. 2015 Nov 13;5:e368
【2】.Milani M, et al. DRP-1 is required for BH3 mimetic-mediated mitochondrial fragmentation and apoptosis. Cell Death Dis. 2017 Jan 12;8(1):e2552
【3】.Kawakami H, et al. Mutant BRAF Upregulates MCL-1 to Confer Apoptosis Resistance that Is Reversed by MCL-1 Antagonism and Cobimetinib in Colorectal Cancer. Mol Cancer Ther. 2016 Dec;15(12):3015-3027
【4】.Phillips DC, et al. Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199). Blood Cancer J. 2015 Nov 13;5:e368
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


